Heat shock proteins as vaccine adjuvants in infections and cancer

Drug Discovery Today

Volumn 11, Issue 11-12, 2006, Pages 534-540

  Segal, Brahm H ^a   Wang, Xiang Yang ^a   Dennis, Carly G ^a   Youn, Richard ^a   Repasky, Elizabeth A ^a   Manjili, Masoud H ^b   Subjeck, John R ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AG 702; ANTIVIRUS AGENT; BCG VACCINE; CHAPERONE; DNA VACCINE; GLYCOPROTEIN 96; HEAT SHOCK PEPTIDE COMPLEX 96; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 110; HEAT SHOCK PROTEIN 110 INTERCELLULAR DOMAIN COMPLEX; HEAT SHOCK PROTEIN 110 INTERCELLULAR GLYCOPROTEIN 100 COMPLEX; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN PEPTIDE COMPLEX 96; MYCOBACTERIUM VACCINE; ONCOPHAGE; RECOMBINANT PROTEIN; TUMOR ANTIGEN; TUMOR VACCINE; UNCLASSIFIED DRUG; VACCINE;

ABSENCE OF SIDE EFFECTS; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; CANCER; CELLULAR IMMUNITY; CLINICAL TRIAL; DENDRITIC CELL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EFFECTOR CELL; FEVER; HOMEOSTASIS; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; IMMUNOTHERAPY; INFECTION; INNATE IMMUNITY; MOLECULAR BIOLOGY; NATURAL KILLER CELL; NONHUMAN; PHYSIOLOGY; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN TRANSPORT; RADIATION; REVIEW; STRESS; T LYMPHOCYTE; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BACTERIAL VACCINES; CANCER VACCINES; HEAT-SHOCK PROTEINS; HUMANS; INFECTION; NEOPLASMS; VACCINES;

EID: 33646675316     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drudis.2006.04.016     Document Type: Review

References (70)

1. Gamvrellis A., et al. Vaccines that facilitate antigen entry into dendritic cells. Immunol. Cell Biol. 82 (2004) 506-516
2. Easton D.P., et al. The hsp110 and Grp170 stress proteins: newly recognized relatives of the Hsp70s. Cell Stress Chaperones 5 (2000) 276-290
3. Chen X., et al. The 170-kDa glucose regulated stress protein is a large HSP70-, HSP110-like protein of the endoplasmic reticulum. FEBS Lett. 380 (1996) 68-72
4. Craven R.A., et al. A novel subfamily of HSP70s in the endoplasmic reticulum. Trends Cell Biol. 7 (1997) 277
5. Manjili M.H., et al. Cancer immunotherapy: stress proteins and hyperthermia. Int. J. Hyperthermia 18 (2002) 506-520
6. Manjili M.H., et al. Immunotherapy of cancer using heat shock proteins. Front. Biosci. 7 (2002) d43-d52
7. Manjili M.H., et al. Cancer immunotherapy and heat-shock proteins: promises and challenges. Expert Opin. Biol. Ther. 4 (2004) 363-373
8. Facciponte J.G., et al. Heat shock proteins and scavenger receptors: role in adaptive immune responses. Immunol. Invest. 34 (2005) 325-342
9. Castelli C., et al. Heat shock proteins: biological functions and clinical application as personalized vaccines for human cancer. Cancer Immunol. Immunother. 53 (2004) 227-233
10. Srivastava P. Roles of heat-shock proteins in innate and adaptive immunity. Nat. Rev. Immunol. 2 (2002) 185-194
11. Todryk S.M., et al. Heat shock proteins refine the danger theory. Immunology 99 (2000) 334-337
12. Gallucci S., and Matzinger P. Danger signals: SOS to the immune system. Curr. Opin. Immunol. 13 (2001) 114-119
13. Matzinger P. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12 (1994) 991-1045
14. Basu S., et al. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kB pathway. Int. Immunol. 12 (2000) 1539-1546
15. Ullrich S.J., et al. A mouse tumor-specific transplantation antigen is a heat-shock related protein. Proc. Natl. Acad. Sci. U. S. A. 83 (1986) 3121-3125
16. Udono H., and Srivastava P.K. Comparison of tumor-specific immunogenicities of stress-induced proteins gp96, hsp90 and hsp70. J. Immunol. 152 (1994) 5398-5403
17. Tamura Y., et al. Immunotherapy of tumor with autologous tumor-derived heat shock protein preparations. Science 278 (1997) 117-120
18. Basu S., and Srivastava P.K. Calreticulin, a peptide-binding chaperone of the endoplasmic reticulum, elicits tumor- and peptide-specific immunity. J. Exp. Med. 189 (1999) 797-802
19. Lindquist S., and Craig E.A. The heat-shock proteins. Annu. Rev. Genet. 22 (1988) 631-677
20. Clarke A.R. Molecular chaperones in protein folding and translocation. Curr. Opin. Struct. Biol. 6 (1996) 43-50
21. Bohen S.P., et al. Hold'em and fold'em: chaperones and signal transduction. Science 268 (1995) 1303-1304
22. Przepiorka D., and Srivastava P.K. Heat shock protein-peptide complexes as immunotherapy for human cancer. Mol. Med. Today 4 (1998) 478-484
23. Asea A., et al. HSP70 stimulates cytokine production through a CD14-dependent pathway, demonstrating its dual role as a chaperone and cytokine. Nat. Med. 6 (2000) 435-442
24. Singh-Jasuja H., et al. The heat shock protein gp96 induces maturation of dendritic cells and down-regulation of its receptor. Eur. J. Immunol. 30 (2000) 2211-2215
25. Kelly J.M., et al. Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection. Nat. Immunol. 3 (2002) 83-90
26. Michaelsson J., et al. A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition. J. Exp. Med. 196 (2002) 1403-1414
27. Strbo N., et al. Perforin is required for innate and adaptive immunity induced by heat shock protein gp96. Immunity 18 (2003) 381-390
28. Chen X., et al. Tumor cell membrane-bound heat shock protein 70 elicits antitumor immunity. Immunol. Lett. 84 (2002) 81-87
29. Gastpar R., et al. Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells. Cancer Res. 65 (2005) 5238-5247
30. Massa C., et al. Chaperon and adjuvant activity of hsp70: different natural killer requirement for cross-priming of chaperoned and bystander antigens. Cancer Res. 65 (2005) 7942-7949
31. Pilla L., et al. Natural killer and NK-Like T-cell activation in colorectal carcinoma patients treated with autologous tumor-derived heat shock protein 96. Cancer Res. 65 (2005) 3942-3949
32. Li Z., et al. Combination of imatinib mesylate with autologous leukocyte-derived heat shock protein and chronic myelogenous leukemia. Clin. Cancer Res. 11 (2005) 4460-4468
33. Menoret A. Purification of recombinant and endogenous HSP70s. Methods 32 (2004) 7-12
34. Bausinger H., et al. LPS-free heat-shock protein 70 fails to induce APC activation. Eur. J. Immunol. 32 (2002) 3708-3713
35. Gao B., and Tsan M.F. LPS contamination in recombinant human heat shock protein 70 (Hsp70) preparation is responsible for the induction of tumor necrosis factor alpha release by murine macrophages. J. Biol. Chem. 278 (2003) 174-179
36. Osterloh A., et al. Lipopolysaccharide-free heat shock protein 60 activates T cells. J. Biol. Chem. 279 (2004) 47906-47911
37. Vabulas R.M., et al. HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway. J. Biol. Chem. 277 (2002) 15107-15112
38. Singh-Jasuja H., et al. Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis. J. Exp. Med. 191 (2000) 1965-1974
39. Gullo C.A., and Teoh G. Heat shock proteins: to present or not, that is the question. Immunol. Lett. 94 (2004) 1-10
40. Zugel U., and Kaufmann S.H. Immune response against heat shock proteins in infectious diseases. Immunobiology 201 (1999) 22-35
41. Casadevall A. Antibody-mediated immunity against intracellular pathogens: two-dimensional thinking comes full circle. Infect. Immun. 71 (2003) 4225-4228
42. Casadevall A., and Pirofski L.A. Exploiting the redundancy in the immune system: vaccines can mediate protection by eliciting 'unnatural' immunity. J. Exp. Med. 197 (2003) 1401-1404
43. Kang H.K., et al. Toxoplasma gondii-derived heat shock protein 70 stimulates the maturation of human monocyte-derived dendritic cells. Biochem. Biophys. Res. Commun. 322 (2004) 899-904
44. Long K.H., et al. Identification of heat shock protein 60 as the ligand on Histoplasma capsulatum that mediates binding to CD18 receptors on human macrophages. J. Immunol. 170 (2003) 487-494
45. Scheckelhoff M., and Deepe Jr. G.S. The protective immune response to heat shock protein 60 of Histoplasma capsulatum is mediated by a subset of V beta 8.1/8. 2+ T cells. J. Immunol. 169 (2002) 5818-5826
46. Bloom B.R., et al. Experimental approaches to mechanisms of protection and pathogenesis in M. tuberculosis infection. Immunobiology 191 (1994) 526-536
47. Colaco C.A., et al. BCG (Bacille Calmette-Guerin) HspCs (heat-shock protein-peptide complexes) induce T-helper 1 responses and protect against live challenge in a murine aerosol challenge model of pulmonary tuberculosis. Biochem. Soc. Trans. 32 (2004) 626-628
48. Bonato V.L., et al. Immune regulatory effect of pHSP65 DNA therapy in pulmonary tuberculosis: activation of CD8+ cells, interferon-gamma recovery and reduction of lung injury. Immunology 113 (2004) 130-138
49. Ferraz J.C., et al. A heterologous DNA priming-Mycobacterium bovis BCG boosting immunization strategy using mycobacterial Hsp70, Hsp65, and Apa antigens improves protection against tuberculosis in mice. Infect. Immun. 72 (2004) 6945-6950
50. Kita Y., et al. Novel recombinant BCG and DNA-vaccination against tuberculosis in a cynomolgus monkey model. Vaccine 23 (2005) 2132-2135
51. Lima K.M., et al. Vaccine adjuvant: it makes the difference. Vaccine 22 (2004) 2374-2379
52. Winau F., et al. Scant activation of CD8 T cells by antigen loaded on heat shock protein. Eur. J. Immunol. 35 (2005) 1046-1055
53. Brenner B.G., and Wainberg Z. Heat shock proteins: novel therapeutic tools for HIV-infection? Expert Opin. Biol. Ther. 1 (2001) 67-77
54. Oglesbee M.J., et al. Role for heat shock proteins in the immune response to measles virus infection. Viral Immunol. 15 (2002) 399-416
55. SenGupta D., et al. Heat shock protein-mediated cross-presentation of exogenous HIV antigen on HLA class I and class II. J. Immunol. 173 (2004) 1987-1993
56. Bogers W.M., et al. CCR5 targeted SIV vaccination strategy preventing or inhibiting SIV infection. Vaccine 22 (2004) 2974-2984
57. Bogers W.M., et al. A novel HIV-CCR5 receptor vaccine strategy in the control of mucosal SIV/HIV infection. AIDS 18 (2004) 25-36
58. Hoos A., and Levey D.L. Vaccination with heat shock protein-peptide complexes: from basic science to clinical applications. Expert Rev. Vaccines 2 (2003) 369-379
59. Bruserud O., et al. Is targeted chemotherapy an alternative to immunotherapy in chronic lymphocytic leukemia?. Cancer Immunol. Immunother. 55 (2005) 221-228
60. Faure O., et al. Inducible Hsp70 as target of anticancer immunotherapy: Identification of HLA-A*0201-restricted epitopes. Int. J. Cancer 108 (2004) 863-870
61. Srivastava P.K., et al. Heat shock proteins come of age: primitive functions acquire new roles in an adaptive world. Immunity 8 (1998) 657-665
62. Lewis J.J. Therapeutic cancer vaccines: using unique antigens. Proc. Natl. Acad. Sci. U. S. A. 101 Suppl 2 (2004) 14653-14656
63. Belli F., et al. Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: clinical and immunologic findings. J. Clin. Oncol. 20 (2002) 4169-4180
64. Mazzaferro V., et al. Vaccination with autologous tumor-derived heat-shock protein gp96 after liver resection for metastatic colorectal cancer. Clin. Cancer Res. 9 (2003) 3235-3245
65. Wood C.G., et al. A multicenter randomized study of adjuvant heat-shock protein peptide-complex 96 (HSPPC-96) vaccine in patients with high-risk of recurrence after nephrectomy for renal cell carcinoma (RCC) - a preliminary report. J. Clin. Oncol. 22 (2004) Abstract#2618
66. Manjili M.H., et al. Development of a recombinant HSP110-HER-2/neu vaccine using the chaperoning properties of HSP110. Cancer Res. 62 (2002) 1737-1742
67. Manjili M.H., et al. HSP110-Her-2/neu chaperone complex vaccine induces protective immunity against spontaneous mammary tumors. J. Immunol. 171 (2003) 4054-4061
68. Wang X.Y., et al. Targeted immunotherapy using reconstituted chaperone complexes of heat shock protein 110 and melanoma-associated antigen gp100. Cancer Res. 63 (2003) 2553-2560
69. Wang X.Y., et al. Hsp110 over-expression increases the immunogenicity of the murine CT26 colon tumor. Cancer Immunol. Immunother. 51 (2002) 311-319
70. Huang C., et al. A novel anticancer approach: SEA-anchored tumor cells expressing heat shock protein 70 onto the surface elicit strong anticancer efficacy. Immunol Lett. 101 (2005) 71-80